INTRODUCTION
A decreasing of the expression of CD4 receiver in the surface of the infected cells by Nef is one of the most important events during the infection by HIV-1. The identification of Nef inhibitors is very important to the treatment of HIV infection. The development of new therapies and methods of synthesis of Nef antagonists is a new and highly specific therapeutic approach and aims at eliminating the side effects involved with the existing anti-retroviral cocktail. To achieve this goal, we propose to synthesize a series of inhibitors of degradation of CD4 by Nef beginning with molecular modeling studies of the Nef protein and its catalytic domains involved in this function. 1 In this sense, compound 1 seems to be one of the most promising ( Figure 1 ). 
RESULTS AND DISCUSSION
The first step of the synthesis of compound 1 is the sulfonation of piperazine 3 in the presence of pyridine in dichloromethane, affording compound 4 in 92% yield (Scheme 1). In the final stage of the synthesis, compound 6 was coupled with 1,2,4-triazole-3-carboxylic acid 7. Some coupling agents were tested, such as DCC / DMAP, EDC and PYBOP. Only the latter was able to provide compound 1 in 84% yield (Scheme 2).
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CONCLUSION
Compound 1, a potential inhibitor of HIV-1 Nef, was efficiently obtained from piperazine by a 3-step sequence and its pharmacological properties will be now evaluated.
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